Trial Condition(s):

Diabetes Mellitus, Type 1

Efficacy and tolerability of acarbose (BAY g 5421) compared with placebo in diabetic children on conventional insulin treatment

Bayer Identifier:

Trial_0665

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Terminated/Withdrawn

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

September1991

September1993

Phase

Could I receive a placebo?

Products

Acarbose (Precose/Glucobay, BAYG5421)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations

Diabetes Mellitus, Type 1

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

6 Years

16 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information